Molecule Details
InChIKeyHDOZVRUNCMBHFH-UHFFFAOYSA-N
Compound NameZotepine
Canonical SMILESCN(C)CCOC1=Cc2ccccc2Sc2ccc(Cl)cc21
Clinical Status Clinical Multi-Target
Targets (Human+Pathogen)26
Pfam Stratification Cross-Family
Avg pChEMBL7.26
SourceBindingDB;ChEMBL;TTD_MultiTarget
2D Structure
2D structure
Activity Profile
DrugBank Annotations
DrugBank ID DB09225
Drug NameZotepine
CAS Number26615-21-4
Groups approved withdrawn
ATC Codes N05AX11
DescriptionZotepine, with the formula (2-chloro-11-(2-dimethyl-amino-ethoxy)-dibenzo thiepin, is a neuroleptic drug. It was designed and synthesized by Fujisawa Pharmaceutical Co Ltd.[A31855] It has been used as an antipsychotic in Japan, India and some places in Europe like UK and Germany since 1980's.[A31857...

Categories: Antidepressive Agents Antipsychotic Agents Antipsychotic Agents (Second Generation [Atypical]) Central Nervous System Agents Central Nervous System Depressants Cytochrome P-450 CYP1A2 Substrates Cytochrome P-450 CYP3A Substrates Cytochrome P-450 CYP3A4 Substrates Cytochrome P-450 Substrates Dopamine Antagonists Dopamine D2 Receptor Antagonists Heterocyclic Compounds, Fused-Ring Nervous System Neurotoxic agents Psycholeptics Psychotropic Drugs Serotonergic Drugs Shown to Increase Risk of Serotonin Syndrome Serotonin 5-HT2 Receptor Antagonists Serotonin 5-HT2A Receptor Antagonists Serotonin Agents Serotonin Receptor Antagonists Sulfur Compounds Thiepins Tranquilizing Agents
Cross-references: BindingDB: 35255 ChEBI: 32316 CHEMBL285802 ChemSpider: 5534 D01321 PDB: ZOT PubChem:5736 PubChem:310265131 RxCUI: 40003 Wikipedia: Zotepine ZINC: ZINC000000002264
Target Activities (26)
Target Gene Organism Category Pfam pChEMBL Type Source
P35367 HRH1 Homo sapiens Human PF00001 8.8 Ki ChEMBL;BindingDB
P28223 HTR2A Homo sapiens Human PF00001 8.8 Ki ChEMBL;BindingDB
P28335 HTR2C Homo sapiens Human PF00001 8.5 Ki ChEMBL;BindingDB
P25100 ADRA1D Homo sapiens Human PF00001 8.5 Ki ChEMBL
P35348 ADRA1A Homo sapiens Human PF00001 8.5 pIC50 TTD_MultiTarget
P35368 ADRA1B Homo sapiens Human PF00001 8.5 Ki ChEMBL
P35462 DRD3 Homo sapiens Human PF00001 8.2 Ki ChEMBL;BindingDB
P14416 DRD2 Homo sapiens Human PF00001 8.0 Ki ChEMBL;BindingDB
P11229 CHRM1 Homo sapiens Human PF00001 7.7 Ki BindingDB
P21917 DRD4 Homo sapiens Human PF00001 7.4 Ki ChEMBL;BindingDB
P21728 DRD1 Homo sapiens Human PF00001 7.3 Ki ChEMBL;BindingDB
P28222 HTR1B Homo sapiens Human PF00001 7.3 Ki BindingDB
P28221 HTR1D Homo sapiens Human PF00001 7.2 Ki BindingDB
P20309 CHRM3 Homo sapiens Human PF00001 7.1 Ki BindingDB
P18089 ADRA2B Homo sapiens Human PF00001 6.8 Ki ChEMBL;BindingDB
P18825 ADRA2C Homo sapiens Human PF00001 6.8 Ki ChEMBL;BindingDB
P08913 ADRA2A Homo sapiens Human PF00001 6.7 Ki ChEMBL;BindingDB
P08172 CHRM2 Homo sapiens Human PF00001 6.7 Ki BindingDB
P08912 CHRM5 Homo sapiens Human PF00001 6.6 Ki BindingDB
P28566 HTR1E Homo sapiens Human PF00001 6.5 Ki BindingDB
P08908 HTR1A Homo sapiens Human PF00001 6.5 Ki ChEMBL;BindingDB
P08173 CHRM4 Homo sapiens Human PF00001 6.3 Ki ChEMBL;BindingDB
Q9UBN7 HDAC6 Homo sapiens Human PF00850 PF02148 6.2 IC50 ChEMBL
P20366 TAC1 Homo sapiens Human PF02202 6.0 Ki BindingDB
P21731 TBXA2R Homo sapiens Human PF00001 6.0 Ki BindingDB
P31645 SLC6A4 Homo sapiens Human PF03491 PF00209 6.0 Ki BindingDB
DrugBank Target Actions (10)
Target Gene Target Name Action Type
P05177 CYP1A2 Cytochrome P450 1A2 substrate enzymes
P08684 CYP3A4 Cytochrome P450 3A4 substrate enzymes
P14416 DRD2 D(2) dopamine receptor antagonist targets
P21728 DRD1 D(1) dopamine receptor antagonist targets
P23975 SLC6A2 Sodium-dependent noradrenaline transporter antagonist targets
P28223 HTR2A 5-hydroxytryptamine receptor 2A antagonist targets
P31645 SLC6A4 Sodium-dependent serotonin transporter antagonist targets
P34969 HTR7 5-hydroxytryptamine receptor 7 antagonist targets
P50406 HTR6 5-hydroxytryptamine receptor 6 antagonist targets
P28223 HTR2A 5-hydroxytryptamine receptor 2A inhibitor targets